Explore / Clinical trial
Clinical trial

Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study

Anders Fink-Jensen, MD, DMSciUnknownPhase 2Started Feb 9, 202310 enrolledDenmarkNCT04718792

Abstract

The purpose of this project is to assess the feasibility and safety of administering a single dose of psilocybin to patients diagnosed with alcohol use disorder (AUD). In addition the investigators will establish the pharmacokinetic properties of the active metabolite psilocin. This is the first step in a research project that has the overall aim to evaluate the efficacy of a single administration of psilocybin as an intervention for treatment of AUD.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinAddiction

Keywords

alcohol use disorderpsychedelicspharmacokineticspsilocinfeasibilityAlcohol Use Disorder (AUD)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.